| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.7 | 0.008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |